These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 12374760

  • 1. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
    Weinhofer I, Forss-Petter S, Zigman M, Berger J.
    Hum Mol Genet; 2002 Oct 15; 11(22):2701-8. PubMed ID: 12374760
    [Abstract] [Full Text] [Related]

  • 2. Cholesterol regulates ABCD2 gene expression: implications for X-linked adrenoleukodstrophy.
    Weinhofer I, Forss-Petter S, Zigman M, Berger J.
    Adv Exp Med Biol; 2003 Oct 15; 544():331-2. PubMed ID: 14713249
    [No Abstract] [Full Text] [Related]

  • 3. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
    Muneer Z, Wiesinger C, Voigtländer T, Werner HB, Berger J, Forss-Petter S.
    PLoS One; 2014 Oct 15; 9(9):e108655. PubMed ID: 25255441
    [Abstract] [Full Text] [Related]

  • 4. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
    Singh J, Khan M, Singh I.
    Biochim Biophys Acta; 2013 Apr 15; 1831(4):747-58. PubMed ID: 23318275
    [Abstract] [Full Text] [Related]

  • 5. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
    Weinhofer I, Forss-Petter S, Kunze M, Zigman M, Berger J.
    FEBS Lett; 2005 Oct 24; 579(25):5512-6. PubMed ID: 16213491
    [Abstract] [Full Text] [Related]

  • 6. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
    Weber FD, Wiesinger C, Forss-Petter S, Regelsberger G, Einwich A, Weber WH, Köhler W, Stockinger H, Berger J.
    Hum Mol Genet; 2014 May 15; 23(10):2542-50. PubMed ID: 24363066
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy.
    Rampler H, Weinhofer I, Netik A, Forss-Petter S, Brown PJ, Oplinger JA, Bugaut M, Berger J.
    Mol Genet Metab; 2003 Dec 15; 80(4):398-407. PubMed ID: 14654352
    [Abstract] [Full Text] [Related]

  • 8. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
    Singh J, Khan M, Singh I.
    J Lipid Res; 2011 Nov 15; 52(11):2056-69. PubMed ID: 21891797
    [Abstract] [Full Text] [Related]

  • 9. ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.
    Park CY, Kim HS, Jang J, Lee H, Lee JS, Yoo JE, Lee DR, Kim DW.
    PLoS One; 2013 Nov 15; 8(2):e56242. PubMed ID: 23437103
    [Abstract] [Full Text] [Related]

  • 10. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.
    Fourcade S, Savary S, Albet S, Gauthé D, Gondcaille C, Pineau T, Bellenger J, Bentejac M, Holzinger A, Berger J, Bugaut M.
    Eur J Biochem; 2001 Jun 15; 268(12):3490-500. PubMed ID: 11422379
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC, Zhang HP, Smith KD.
    Mol Genet Metab; 2001 Jun 15; 74(1-2):256-63. PubMed ID: 11592822
    [Abstract] [Full Text] [Related]

  • 12. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J, Olle B, Suhail H, Felicella MM, Giri S.
    J Neurochem; 2016 Jul 15; 138(1):86-100. PubMed ID: 26849413
    [Abstract] [Full Text] [Related]

  • 13. Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation.
    Weinhofer I, Kunze M, Rampler H, Bookout AL, Forss-Petter S, Berger J.
    J Biol Chem; 2005 Dec 16; 280(50):41243-51. PubMed ID: 16249184
    [Abstract] [Full Text] [Related]

  • 14. CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy.
    Raas Q, Gondcaille C, Hamon Y, Leoni V, Caccia C, Ménétrier F, Lizard G, Trompier D, Savary S.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May 16; 1864(5):704-714. PubMed ID: 30769094
    [Abstract] [Full Text] [Related]

  • 15. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
    Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J.
    Hum Mol Genet; 1999 May 16; 8(5):907-13. PubMed ID: 10196381
    [Abstract] [Full Text] [Related]

  • 16. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
    Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J.
    J Biol Chem; 2013 Jun 28; 288(26):19269-79. PubMed ID: 23671276
    [Abstract] [Full Text] [Related]

  • 17. ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
    Buda A, Forss-Petter S, Hua R, Jaspers Y, Lassnig M, Waidhofer-Söllner P, Kemp S, Kim P, Weinhofer I, Berger J.
    Biomolecules; 2023 Aug 31; 13(9):. PubMed ID: 37759733
    [Abstract] [Full Text] [Related]

  • 18. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M, Beeson C, Singh A, Singh I.
    J Neurochem; 2015 May 31; 133(3):380-96. PubMed ID: 25393703
    [Abstract] [Full Text] [Related]

  • 19. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
    Baarine M, Andréoletti P, Athias A, Nury T, Zarrouk A, Ragot K, Vejux A, Riedinger JM, Kattan Z, Bessede G, Trompier D, Savary S, Cherkaoui-Malki M, Lizard G.
    Neuroscience; 2012 Jun 28; 213():1-18. PubMed ID: 22521832
    [Abstract] [Full Text] [Related]

  • 20. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
    Morita M, Shimozawa N, Kashiwayama Y, Suzuki Y, Imanaka T.
    Curr Drug Targets; 2011 May 28; 12(5):694-706. PubMed ID: 21039332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.